Make the most of 2020. Read the FT in print for just $99.
Add this topic to your myFT Digest for news straight to your inbox
Consumer spending on many illegal substances grew rapidly after 1965
Some states have targeted family members in opioid lawsuits after company bankruptcy
The artist tells the FT why she ‘can’t stand back and watch another generation disappear’
Israeli drugmaker reports widening quarterly loss but lifts outlook
Four plaintiffs aim to persuade others to sign on to framework
Teva and distributors’ deal came as first federal trial on US addiction crisis was due to open
First federal lawsuit to proceed after local governments call offer ‘inadequate’
Opiod maker owned by Sackler family has yet to reach deal with all attorneys-general
New York, Pennsylvania and Washington among those to rebuff settlement
Drug companies are facing trial but more public funding is needed
Companies feel pressure to temper profit-seeking with social duty
Plaintiffs must decide whether to accept the deal by Friday as company eyes bankruptcy
Teva and Endo International tumble after Oklahoma judge’s ruling
Oklahoma had sought up to $17bn from healthcare company over deadly epidemic
Oklahoma to decide whether healthcare company contributed to deadly epidemic
State tries unusual legal move over alleged ‘massive cash transfers’ to Sackler family members
Court cases targeting big pharma are just a taste of what is to come
US president Donald Trump backs down on asking about citizenship in 2020 US census
Reckitt Benckiser’s $1.4bn settlement is the largest penalty so far linked to the epidemic
Deal over addiction treatment marketing is largest fine so far in painkiller epidemic
$1.4bn settlement is huge but has put end to troublesome source of cost, doubt and distraction
OneFifteen in Dayton aims to collect insights on 1,000 annual outpatient addicts
Lawyers for 1,800 plaintiffs vow to ‘actively pursue’ drugmakers regardless of Chapter 11 filing
Group buckles under weight of legal liabilities in wake of US addiction crisis
Group admits to illegal conduct when widely promoting fentanyl-based spray
